Testing and Diagnosis
These webinars address topics in prostate cancer testing and diagnosis including: biomarkers for prostate cancer, PSA testing and understanding pathology reports.
2019 Webinars
Understanding Your Pathology Report
February 19, 2019
Dr. Dominique Trudel highlights how pathologists interpret biopsy test results. This includes understanding a tumour grade, volume and stage. A pathologist will use this information to determine whether the cancer is likely to spread or be aggressive, which will influence treatment strategies.
2016 Webinars
Amplifying blood biomarkers with ultrasound to help predict the aggressiveness of prostate cancer
May 31, 2016
Join Dr. Roger Zemp to learn about how:
• Blood biomarkers are used in the detection of prostate cancer but may also offer promise in determining how aggressive a prostate cancer is
• Current biomarker testing cannot yet predict aggressiveness, in part due to the low levels of informative prostate biomarkers in the blood
2015 Webinars
July 14, 2015
In this Expert Angle webinar, Dr. Dominique Trudel presents "Understanding Your Pathology Report". During this webinar, you'll learn what is the significance of the pathology report, how is the prostate transformed to make it readable to the pathologist, and how does a pathologist analyze the prostate biopsy and the surgery specimen?
2014 Webinars
April 29, 2014
During this webinar, Dr. Black discusses the evolving role of Magnetic Resonance Imaging (MRI) in prostate cancer, including its use in the early detection of prostate cancer, active surveillance for men with low risk prostate cancer, improving the accuracy of biopsies, and prostate cancer staging.
July 22, 2014
During this webinar, Dr. John Lewis will be discussing the use of biomarkers in prostate cancer diagnosis, including how biomarkers such as PSA are used today for prostate cancer management and how new biomarkers will allow patients and their physicians to make better treatment decisions.
November 6, 2014
In response to the recommendations against PSA testing by the Canadian Task Force on Preventative Health Care, this Expert Angle webinar highlights the benefits of PSA testing with Dr. Andrew Loblaw. In particular, Dr. Loblaw discusses the importance of active surveillance and its adoption in Canada, the need to measure baseline PSA to determine prostate cancer risk, and the use of modeling data to augment cohort data.
2013 Webinars
October 10, 2013
Dr. Tom Pickles presents “Prostate Cancer and PSA Testing”. This webinar covers what is PSA, diagnosis, screening, pre-treatment, and post-treatment.
En Français
11 août 2015
Au cours de cette présentation, vous apprendrez comment la prostate est transformée pour être analysée par le pathologist, comment le pathologiste analyse la biopsie et le spécimen de chirurgie, et quelle est la signification du rapport de pathologie.
1 septembre 2015
Regardez ce webinaire préenregistré de l’Angle de l’expert avec Dr Alexandre Zlotta. Facteurs de risque et diagnostic précoce du cancer de la prostate: ou en sommes-nous? Thèmes abordés...nouveaux facteurs de risque y compris les genes BRCA2, differences majeures entre prévalence, incidence et mortalité dues au cancer de la prostate, les nouveaux tests diagnostiques moléculaires, et la place grandissante de la resonance magnetique nucléaire.